Alterity Therapeutics Correlations
ATHE Stock | USD 3.72 0.27 6.77% |
The current 90-days correlation between Alterity Therapeutics and Anebulo Pharmaceuticals is 0.18 (i.e., Average diversification). The correlation of Alterity Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Alterity Therapeutics Correlation With Market
Good diversification
The correlation between Alterity Therapeutics and DJI is -0.05 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Alterity Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
Alterity |
Moving together with Alterity Stock
0.61 | ACAD | ACADIA Pharmaceuticals Downward Rally | PairCorr |
0.66 | APLS | Apellis Pharmaceuticals | PairCorr |
0.62 | BFRI | Biofrontera | PairCorr |
0.69 | TKNO | Alpha Teknova | PairCorr |
Moving against Alterity Stock
0.77 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
0.76 | DNLI | Denali Therapeutics Buyout Trend | PairCorr |
0.65 | UPC | Universe Pharmaceuticals | PairCorr |
0.55 | FOLD | Amicus Therapeutics | PairCorr |
0.4 | IONS | Ionis Pharmaceuticals | PairCorr |
0.36 | EVOK | Evoke Pharma | PairCorr |
0.36 | LLY | Eli Lilly | PairCorr |
0.75 | AMGN | Amgen Inc | PairCorr |
0.67 | PAHC | Phibro Animal Health | PairCorr |
0.65 | RARE | Ultragenyx | PairCorr |
0.61 | ALNY | Alnylam Pharmaceuticals | PairCorr |
0.53 | SHPH | Shuttle Pharmaceuticals | PairCorr |
0.43 | APGE | Apogee Therapeutics, | PairCorr |
0.4 | SNOA | Sonoma Pharmaceuticals | PairCorr |
0.33 | ABBV | AbbVie Inc | PairCorr |
0.86 | VNTN | VentureNet Capital | PairCorr |
0.64 | AFFL | Affiliated Resources Corp | PairCorr |
0.52 | 688520 | Sinocelltech Group | PairCorr |
0.31 | 688089 | Cabio Biotech Wuhan | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Alterity Stock performing well and Alterity Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Alterity Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
ANEB | 4.31 | (0.08) | 0.00 | (1.57) | 0.00 | 7.64 | 35.55 | |||
PMVP | 1.81 | 0.10 | 0.03 | 0.38 | 2.26 | 4.35 | 13.98 | |||
ANTX | 2.96 | 0.50 | 0.17 | 0.59 | 2.34 | 8.94 | 28.89 | |||
ELYM | 3.62 | (1.10) | 0.00 | (1.35) | 0.00 | 6.00 | 22.16 | |||
HCWB | 12.16 | 2.92 | 0.30 | (0.95) | 7.38 | 10.00 | 352.85 | |||
TARA | 5.81 | 2.25 | 0.43 | (17.66) | 3.82 | 13.00 | 78.24 | |||
VCNX | 7.68 | (0.70) | 0.00 | 0.45 | 0.00 | 12.36 | 85.55 | |||
MNPR | 18.73 | 9.29 | 0.76 | (0.84) | 8.04 | 14.91 | 653.56 | |||
MIRO | 4.85 | 0.43 | 0.07 | 1.74 | 5.26 | 11.73 | 38.49 | |||
SRZN | 5.77 | 0.68 | 0.12 | (3.66) | 5.36 | 19.44 | 33.59 |
Alterity Therapeutics Corporate Management
Robert Cherny | Head Research | Profile | |
BBus CA | Company Sec | Profile | |
BSc BSc | CoFounder Chairman | Profile | |
Kathryn Andrews | Chief Officer | Profile | |
Steven Targum | Chief Advisor | Profile | |
CPA BCom | Chief Officer | Profile | |
Steven MD | Chief Advisor | Profile |